Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 3
1990 1
1994 1
1995 3
1996 2
1997 2
1998 4
2000 2
2001 1
2002 2
2004 2
2005 3
2006 3
2007 1
2009 2
2021 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Comparative nasal airflow with loratadine-pseudoephedrine and fluticasone nasal spray for allergic rhinitis.
Ng CC, Romaikin D, Steacy LM, Stevens DA, Walker TJ, Adams DE, Ellis AK. Ng CC, et al. Ann Allergy Asthma Immunol. 2021 Sep;127(3):342-348.e2. doi: 10.1016/j.anai.2021.05.001. Epub 2021 May 14. Ann Allergy Asthma Immunol. 2021. PMID: 34000435 Free article. Clinical Trial.
BACKGROUND: Although it is known that oral antihistamine-pseudoephedrine combination tablets have a faster onset than intranasal corticosteroid sprays in the treatment of allergic rhinitis after the first dose, the magnitude of change has not been measured in a comparative …
BACKGROUND: Although it is known that oral antihistamine-pseudoephedrine combination tablets have a faster onset than intranasal cort …
[Assessment of the clinical efficacy and safety of epinastine plus pseudoephedrine vs loratadine plus pseudoephedrine in perennial allergic rhinitis].
Hernández Colín D, González Díaz SN, Rodríguez Medina R, Aguilar Angeles D, González Gámez J, Becerril Angeles M, Orea Solano M, Domínguez Henkel R, Segovia Ayala C. Hernández Colín D, et al. Rev Alerg Mex. 2004 Jan-Feb;51(1):23-8. Rev Alerg Mex. 2004. PMID: 15119752 Clinical Trial. Spanish.
OBJECTIVE: To compare the efficacy and safety of epinastine 10 mg plus pseudoephedrine 120 mg vs loratadine 5 mg plus pseudoephedrine 120 mg, twice a day, in the treatment of perennial allergic rhinitis. ...Frequency of side effects was higher in the lorat …
OBJECTIVE: To compare the efficacy and safety of epinastine 10 mg plus pseudoephedrine 120 mg vs loratadine 5 mg plus pseud …
Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
Moinuddin R, deTineo M, Maleckar B, Naclerio RM, Baroody FM. Moinuddin R, et al. Ann Allergy Asthma Immunol. 2004 Jan;92(1):73-9. doi: 10.1016/S1081-1206(10)61713-9. Ann Allergy Asthma Immunol. 2004. PMID: 14756468 Clinical Trial.
CONCLUSIONS: Fexofenadine-pseudoephedrine and loratadine-montelukast have comparable efficacy in improving symptoms, RQLQ scores, and nasal obstruction in seasonal allergic rhinitis. The lack of improvement in sleep in the fexofenadine-pseudoephedrine group i …
CONCLUSIONS: Fexofenadine-pseudoephedrine and loratadine-montelukast have comparable efficacy in improving symptoms, RQLQ scor …
Pharmacokinetics of loratadine and pseudoephedrine following single and multiple doses of once- versus twice-daily combination tablet formulations in healthy adult males.
Kosoglou T, Radwanski E, Batra VK, Lim JM, Christopher D, Affrime MB. Kosoglou T, et al. Clin Ther. 1997 Sep-Oct;19(5):1002-12. doi: 10.1016/s0149-2918(97)80052-5. Clin Ther. 1997. PMID: 9385487 Clinical Trial.
The pharmacokinetic profiles of single and multiple doses of loratadine, descarboethoxyloratadine (DCL) (the major active metabolite of loratadine), and pseudoephedrine were determined in a randomized, open-label, two-way crossover study in 24 healthy men. .. …
The pharmacokinetic profiles of single and multiple doses of loratadine, descarboethoxyloratadine (DCL) (the major active metabolite …
Loratadine-pseudoephedrine in children with allergic rhinitis, a controlled double-blind trial.
Serra HA, Alves O, Rizzo LF, Devoto FM, Ascierto H. Serra HA, et al. Br J Clin Pharmacol. 1998 Feb;45(2):147-50. doi: 10.1046/j.1365-2125.1998.00657.x. Br J Clin Pharmacol. 1998. PMID: 9491827 Free PMC article. Clinical Trial.
AIMS: To conduct a randomized placebo controlled double-blind crossover trial in order to evaluate a loratadine-pseudoephedrine combination (L + PS) in children with seasonal allergic rhinitis. ...
AIMS: To conduct a randomized placebo controlled double-blind crossover trial in order to evaluate a loratadine-pseudoephedrine …
A randomized, double-blind, parallel-group study to compare the efficacy and safety of a once-daily loratadine-pseudoephedrine combination with that of a twice-daily loratadine-pseudoephedrine combination in the treatment of allergic rhinitis.
Chen YA, Chang KP, Lin YS, Hao SP. Chen YA, et al. Eur Arch Otorhinolaryngol. 2007 Sep;264(9):1019-25. doi: 10.1007/s00405-007-0316-y. Epub 2007 Apr 27. Eur Arch Otorhinolaryngol. 2007. PMID: 17464511 Clinical Trial.
The aim of this study is to compare the efficacy and safety of a once-daily loratadine-pseudoephedrine sustained release tablet with that of a twice-daily loratadine-pseudoephedrine in the treatment of patients with allergic rhinitis. ...Non-inferiorit …
The aim of this study is to compare the efficacy and safety of a once-daily loratadine-pseudoephedrine sustained release table …
A comparative study of the side effects between pseudoephedrine in Loratadine plus Pseudoephedrine Sulfate Repetabs Tables and loratadine + pseudoephedrine tablet in treatment of allergic rhinitis in Thai patients.
Supiyaphun P, Chochaipanichnon L, Kerekhanjanarong V, Saengpanich S. Supiyaphun P, et al. J Med Assoc Thai. 2002 Jun;85(6):722-7. J Med Assoc Thai. 2002. PMID: 12322847 Clinical Trial.
The objective of the study was to evaluate the adverse reactions of Loratadine plus Pseudoephedrine Sulfate Repetabs Tables (LTD+PSE Repetabs) (Loratadine 5 mg + Pseudoephedrine 120 mg) twice daily with that of loratadine (5 mg) twice daily and …
The objective of the study was to evaluate the adverse reactions of Loratadine plus Pseudoephedrine Sulfate Repetabs Tables (L …
Efficacy and safety of fixed-dose loratadine/montelukast in seasonal allergic rhinitis: effects on nasal congestion.
Prenner B, Anolik R, Danzig M, Yao R. Prenner B, et al. Allergy Asthma Proc. 2009 May-Jun;30(3):263-9. doi: 10.2500/aap.2009.30.3228. Allergy Asthma Proc. 2009. PMID: 19549427 Clinical Trial.
This study was performed to assess efficacy and safety of a once-daily tablet containing 10 mg of loratadine, an antihistamine, and 10 mg of montelukast, a leukotriene antagonist (SCH 445761) versus placebo and pseudoephedrine (PSE; 240 mg once-daily formulation; ac …
This study was performed to assess efficacy and safety of a once-daily tablet containing 10 mg of loratadine, an antihistamine, and 1 …
A randomized controlled trial of cetirizine plus pseudoephedrine versus loratadine plus pseudoephedrine for perennial allergic rhinitis.
Chiang YC, Shyur SD, Chen TL, Huang LH, Wen TC, Lin MT, Yang HC, Liang PH, Kao YH, Wang TC. Chiang YC, et al. Asian Pac J Allergy Immunol. 2006 Jun-Sep;24(2-3):97-103. Asian Pac J Allergy Immunol. 2006. PMID: 17136873 Free article. Clinical Trial.
The purpose of this study was to compare the safety and efficacy of cetirizine plus pseudoephedrine (C+P) with loratadine plus pseudoephedrine (L+P) in the treatment of perennial allergic rhinitis. ...It was concluded that both cetirizine plus pseudoephedr …
The purpose of this study was to compare the safety and efficacy of cetirizine plus pseudoephedrine (C+P) with loratadine plus …
Efficacy and safety of an extended-release formulation of desloratadine and pseudoephedrine vs the individual components in the treatment of seasonal allergic rhinitis.
Pleskow W, Grubbe R, Weiss S, Lutsky B. Pleskow W, et al. Ann Allergy Asthma Immunol. 2005 Mar;94(3):348-54. doi: 10.1016/S1081-1206(10)60986-6. Ann Allergy Asthma Immunol. 2005. PMID: 15801245 Clinical Trial.
Patients were randomly assigned for 2 weeks to once-daily treatment with desloratadine-pseudoephedrine, 5/240-mg tablets; desloratadine, 5 mg; or pseudoephedrine, 240 mg. Primary efficacy variables for the antihistamine and decongestant components of desloratadine- …
Patients were randomly assigned for 2 weeks to once-daily treatment with desloratadine-pseudoephedrine, 5/240-mg tablets; desloratadi …
33 results